Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Medical device maker Guidant Corporation has initiated legal action against Johnson & Johnson in an attempt to force the healthcare giant to complete its $25.4 billion acquisition of the company.
Subscribe to our email newsletter
Guidant believes that Johnson & Johnson is legally bound to complete the acquisition under their agreement signed in December 2004. However, J&J will argue that recent product recalls and related regulatory investigations into Guidant have had a material adverse effect on the company, thereby invalidating their original deal.
In response to the news that it had become subject of a lawsuit from Guidant, J&J said that it “views the previously announced product recalls at Guidant and the related regulatory investigations, claims and other developments as serious matters affecting both Guidant’s short-term results and long-term outlook.”
Guidant, meanwhile, insists that its recent problems are only short-term and that its business fundamentals remained strong. Nevertheless, shares in Guidant dropped almost 6% following the news of the legal action, whilst Johnson & Johnson’s shares also dropped, but by less than 1%.